Pneumococcal disease remains a significant yet preventable threat to health systems across Europe, causing high levels of morbidity and mortality, particularly among older adults and at-risk populations. Despite the availability of effective vaccines, gaps in immunisation coverage and inconsistent national strategies persist, exacerbating the strain on healthcare systems already facing rising demand from an ageing population and seasonal respiratory illnesses. The European Health Management Association (EHMA) has highlighted the urgent need for stronger policies and coordinated action to address the burden of pneumococcal disease. EHMA’s report explores the impact of this disease on health systems, the challenges posed by its management and the opportunities to mitigate its effects through enhanced vaccination, improved system efficiency and workforce support.
The Growing Burden of Pneumococcal Disease on Health Systems
Pneumococcal disease is a leading cause of severe respiratory illnesses, disproportionately affecting older adults and individuals with chronic health conditions. Its impact is most evident during winter, when it coincides with other seasonal pathogens such as influenza and respiratory syncytial virus (RSV), leading to a surge in healthcare demand. The EHMA has emphasised that this convergence of diseases results in increased hospital admissions, intensive care unit (ICU) utilisation and longer patient stays, which further strain health system resources.
The demand for care not only increases in volume but also in complexity, as patients presenting with pneumococcal disease often have severe symptoms requiring advanced treatments such as mechanical ventilation. Vulnerable groups, including those with non-communicable diseases, face a higher risk of co-morbidities, which compounds the burden on health systems. Yet, many of these outcomes are preventable. Pneumococcal vaccines have proven effective in reducing severe cases and hospitalisation rates. However, the EHMA notes that vaccine uptake remains insufficient due to fragmented immunisation programmes and inconsistent policy implementation across European nations. Addressing these gaps in vaccination coverage is essential to mitigating the disease's impact on healthcare delivery and patient outcomes.
Challenges in Capacity, Efficiency and Sustainability
The EHMA’s findings underscore the significant challenges that pneumococcal disease poses to health systems' capacity and efficiency. Prolonged hospital stays for pneumococcal patients reduce the availability of beds for other critical cases, creating a ripple effect throughout the system. ICU capacity is particularly vulnerable, as seasonal peaks in respiratory illnesses stretch resources to their limits. This lack of capacity often leads to delays in admissions and care, negatively affecting patient outcomes and forcing clinicians to make difficult decisions about prioritisation.
Beyond physical capacity, the disease causes inefficiencies across care pathways. Delays in referrals, longer waiting times for treatments, and increased utilisation of diagnostic and treatment resources create bottlenecks throughout the system. The EHMA highlights that these inefficiencies not only compromise the quality of care but also increase healthcare costs, reducing the long-term sustainability of health systems. A clear solution lies in strengthening pneumococcal vaccination programmes, which offer cost-effective protection and can significantly alleviate system pressures. Integrated preparedness plans that include pneumococcal vaccination alongside other preventive measures, such as those for influenza and RSV, would help ensure health systems are better equipped to handle seasonal surges in demand.
Supporting the Healthcare Workforce
The rising burden of pneumococcal disease also affects healthcare workers, who are already under immense pressure due to staff shortages, increasing workloads and the complex demands of an ageing population. The EHMA’s report identifies the critical role of the workforce in managing the impact of pneumococcal disease, noting that the rising number of cases intensifies stress, burnout and exhaustion among healthcare providers. This overwork creates a negative feedback loop, where staff turnover increases due to burnout, further exacerbating workforce shortages and destabilising the healthcare system.
Healthcare workers in both primary and hospital settings report significant challenges in managing pneumococcal cases, especially during peak seasons. Extended working hours, increased patient acuity and the need to manage multi-morbid cases contribute to a challenging workplace environment that compromises both employee well-being and patient safety. The EHMA highlights the importance of systemic changes to support the workforce, including better mental health resources, training opportunities and staffing adjustments. Vaccination programmes can play a vital role in alleviating this pressure by preventing cases of pneumococcal disease and reducing the overall burden on health services.
Pneumococcal disease is a preventable yet persistent challenge for European health systems, with wide-reaching implications for patients, providers and policymakers. The EHMA has called for urgent action to address this burden through enhanced vaccination strategies, improved surveillance and workforce support. By strengthening pneumococcal immunisation programmes, harmonising data collection and integrating vaccination into broader health system preparedness plans, policymakers can significantly reduce the strain on healthcare services, improve patient outcomes and ensure the sustainability of health systems in the face of future challenges. Investing in these measures is not only a public health priority but also a critical step towards building more resilient healthcare systems across Europe.
Source: EHMA
Image Credit: iStock
